Given the adjuvant biochemical assays demonstrating decreased ARSA enzymatic activity and elevated urine sulfatides, along with the clinical presentation, this variant was determined to be causative and the diagnosis of MLD was confirmed. The gene discussed is ARSA; the disease is metachromatic leukodystrophy.